American Healthcare REIT, Inc. (AHR) - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. American Healthcare REIT, Inc. is a self-managed REIT operating a diversified portfolio of clinical healthcare real estate, including Integrated Senior Health Campuses (ISHC), Senior Housing Operating Properties (SHOP), Outpatient Medical (OM) buildings, and triple-net leased properties. As of the reporting date, the company owned or operated 315 buildings representing approximately 20.1 million square feet of gross leasable area.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Total Revenues | $572.9 million | $523.8 million | $1,656.0 million | $1,527.9 million |
| Net Income (GAAP) | $56.6 million | ($3.1 million) Loss | $59.9 million | ($3.2 million) Loss |
| Net Income Attributable to Controlling Interest | $55.9 million | ($4.1 million) Loss | $59.0 million | ($6.0 million) Loss |
| Diluted EPS | $0.33 | ($0.03) | $0.36 | ($0.05) |
| Net Operating Income (NOI) | $105.8 million | $93.5 million | $303.6 million | $264.4 million |
| FFO Attributable to Controlling Interest | $93.0 million | $35.6 million | $215.7 million | $108.7 million |
| Cash and Cash Equivalents | $147.4 million | $67.9 million | $147.4 million | $67.9 million |
| Total Debt (Mortgage + Credit Facilities) | $1,521.1 million | $1,670.6 million | $1,521.1 million | $1,670.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 9.4% year-over-year for the quarter and 8.4% year-over-year for the nine-month period. This was driven by increased resident occupancy, higher billing rates, and acquisitions in the ISHC and SHOP segments.
- Profitability Turnaround: The company reported a significant shift from a net loss in Q3 2024 to net income in Q3 2025. This improvement was aided by a $14.6 million gain on the re-measurement of a previously held equity interest (Trilogy Opportunity Fund I) and a $21.1 million income tax benefit resulting from the release of valuation allowances on deferred tax assets.
- Impairment Charges: The company recognized a $38.1 million impairment charge on seven OM buildings during the nine months ended September 30, 2025, compared to no impairments in the prior year period.
- Debt Reduction: Total debt decreased by approximately $150 million compared to the prior year, primarily due to the payoff of variable-rate mortgage loans and paydowns on lines of credit using proceeds from equity offerings.
- Acquisitions and Dispositions: During the nine months ended September 30, 2025, the company acquired 15 properties (11 ISHC and 4 SHOP) for approximately $338 million and disposed of 12 properties for approximately $56 million.
Guidance, Outlook, and Risks
- Outlook: Management expects continued inflationary pressures on labor and services but anticipates offsetting these through rent and care fee increases. The company maintains a quarterly distribution of $0.25 per share.
- Liquidity: The company has $600 million available under its $1.15 billion 2024 Credit Facility. It also established a new $1 billion ATM equity offering program in August 2025.
- Risks:
- Regulatory/Tax: The "One Big Beautiful Bill Act" (OBBBA) signed in July 2025 includes estimated $1 trillion in Medicaid spending cuts, which could adversely impact financial performance. The act also increased the REIT asset test limit for Taxable REIT Subsidiaries (TRS) to 25%.
- AI and Cybersecurity: New risk factors were disclosed regarding the use of AI tools, including potential inaccuracies, data privacy issues, and the use of AI by threat actors for cybersecurity attacks.
- Interest Rate Risk: While the company has hedged its variable-rate debt with interest rate swaps, it remains exposed to market fluctuations affecting refinancing costs.
Investor Verification Checklist
- Verify the Sustainability of Net Income: Confirm the extent to which Q3 2025 profitability relies on the one-time $14.6 million gain on re-measurement and the $21.1 million tax benefit release versus core operating performance.
- Assess Impairment Impact: Review the specific details of the $38.1 million impairment charge on OM buildings to understand if this indicates broader portfolio underperformance or isolated asset issues.
- Monitor Medicaid Exposure: Evaluate the potential financial impact of the OBBBA Medicaid spending cuts on the company's ISHC and SHOP segments, which rely heavily on government payors.
- Check Debt Maturities: Review the $550 million term loan maturing in January 2027 and the $600 million revolver maturing in February 2028 to assess refinancing risks in the current interest rate environment.
- Review ATM Offering Utilization: Track the utilization of the new $1 billion ATM program to gauge management's confidence in equity markets and capital raising strategy.